The CFH/FHL-1 H402 allotype has been shown to alter the binding specificity of the CFH protein at the interface between the retinal pigment epithelium and Bruch’s membrane [58–61], which is the relevant location of AMD pathology, and for glycosaminoglycans [62, 63]. The gene discussed is CFH; the disease is age-related macular degeneration.